首页>
外国专利>
ATTENUATION OF ANGIOGENESIS BY USE OF CHONDROITIN SULFATE DEGRADING ENZYMES
ATTENUATION OF ANGIOGENESIS BY USE OF CHONDROITIN SULFATE DEGRADING ENZYMES
展开▼
机译:硫酸软骨素降解酶对血管生成的抑制作用
展开▼
页面导航
摘要
著录项
相似文献
摘要
A highly purified and specific glycosaminoglycan degrading enzyme, chondroitinase AC, and to a lesser extent, chondroitinase B, can be used in the treatment of metastatic cancers and in other disorders characterized by angiogenesis. The enzymatic removal of chondroitin sulfates A and C, and to a lesser extent, chondroitin sulfate B, from cell surfaces directly decreases the ability of tumor cells to invade blood vessels and thus prevents the formation of metastatic, or secondary tumors; inhibits tumor cell growth; and decreases angiogenesis by inhibiting both endothelial cell proliferation and capillary formation. Decreasing the formation of new blood vessels into the tumor in turn decreases the potential for tumor growth, and further decreases the ability of tumor cells to invade the bloodstream. These effects are opposite to the pro-metastatic effects of tumor-secreted heparanase.
展开▼